Security key
75629V104
RECURSION PHARMACEUTICALS, INC. - Common Stock (RXRX)
CUSIP: 75629V104
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 324,266,763
- Total 13F value
- $1,326,312,624
- Share change
- +12,350,513
- Put/Call ratio
- 80%
- SEC-reported price per share
- $4.09
- Number of holders
- 333
- Value change
- +$25,282,966
- Number of buys
- 180
- Number of sells
- 137
- Shares outstanding
- 525,448,476
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
333
Top holders
10
RXRX full security history
Ownership snapshot
Full 13F holder table
RECURSION PHARMACEUTICALS, INC. SEC filings
RECURSION PHARMACEUTICALS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of RXRX - RECURSION PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARK Investment Management...
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
30 Sep 2025
13F
13D/G
3/4/5
Lead comparable stake: 7.2%
13D/G row: ARK Investment Management LLC
Showing 1-6 of 15 holder rows.
Quick read
ARK Investment Management LLC leads the comparable SEC ownership view at 7.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARK Investment Management LLC's linked filing trail.
Comparable ownership
Top 5
ARK Investment Management LLC
7.2%
BAILLIE GIFFORD & CO
4.6%
RA CAPITAL MANAGEMENT, L.P.
2%
VANGUARD GROUP INC
7.6%
BlackRock, Inc.
6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARK Investment Management LLC |
13F
13D/G
Company
|
7.2%
from 13D/G
|
$163,702,036
33,545,499 shares
|
— | 30 Sep 2025 |
| BAILLIE GIFFORD & CO |
13F
13D/G
Company
|
4.6%
from 13D/G
|
$117,016,031
23,978,695 shares
|
— | 30 Sep 2025 |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
2%
|
$44,187,549
7,725,096 shares
|
$0 | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
7.6%
|
$194,127,147
39,780,153 shares
|
— | 30 Sep 2025 |
| BlackRock, Inc. |
13F
Company
|
6%
|
$154,890,053
31,739,765 shares
|
— | 30 Sep 2025 |
| STATE STREET CORP |
13F
Company
|
3.5%
|
$89,152,354
18,268,925 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
333
Shares
324,266,763
Rows available
333
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
321
Q4 2025 holders
333
Holder diff
12
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|